3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is growing attracting clinical scrutiny due to sparse data suggesting different physiological properties. Preliminary studies suggest that 3-HPC may possess independent responses on the brain structure, possibly influencing to some of the unexpected symptoms associated with PCP us